Faculty of Pharmaceutical Sciences , Hokkaido University , Kita-12, Nishi-6 , Kita-ku, Sapporo 060-0812 , Japan.
Center for Research and Education on Drug Discovery , Hokkaido University , Kita-12, Nishi-6 , Kita-ku, Sapporo 060-0812 , Japan.
J Org Chem. 2018 Jul 6;83(13):7085-7101. doi: 10.1021/acs.joc.8b00038. Epub 2018 Feb 23.
Full details of our synthetic studies toward plusbacin A (1), which is a depsipeptide with antibacterial activity, and its dideoxy derivative are described. To establish an efficient synthetic route of 1, a solvent-dependent diastereodivergent Joullié-Ugi three-component reaction (JU-3CR) was used to construct trans-Pro(3-OH) in a small number of steps. Two strategies were investigated toward the total synthesis. In the first synthetic strategy, the key steps were the trans-selective JU-3CR and a macrolactonization at the final stage of the synthesis. The JU-3CR using alkyl isocyanides in 1,1,1,3,3,3-hexafluoroisopropanol provided the trans products, and the coupling of the fragments to prepare the macrocyclization precursor proceeded smoothly. However, attempts toward the macrolactonization did not provide the desired product. Then, the second strategy that included esterification in an initial stage was investigated. Methods for constructing trans-Pro(3-OH) were examined using a convertible isocyanide, which could be converted to a carboxylic acid required for the following amidation. Ester bond formation was achieved through an intermolecular coupling using a hydroxyl-Asp derivative and the corresponding alcohol, and the amidation afforded a linear depsipeptide. The macrolactamization of the linear peptide gave the cyclic depsipeptide, and then the global deprotection accomplished the total synthesis of 1 and its dideoxy derivative.
我们详细描述了具有抗菌活性的 depsipeptide plusbacin A(1)及其去氧衍生物的合成研究。为了建立 1 的有效合成路线,我们使用了溶剂依赖性的非对映异构体发散 Joullié-Ugi 三组分反应(JU-3CR),在少数步骤中构建了反式-Pro(3-OH)。我们研究了两种总合成策略。在第一个合成策略中,关键步骤是反式选择性的 JU-3CR 和合成后期的大环内酯化。在 1,1,1,3,3,3-六氟异丙醇中使用烷基异氰酸酯的 JU-3CR 提供了反式产物,并且碎片的偶联以制备大环化前体顺利进行。然而,大环内酯化的尝试没有得到所需的产物。然后,我们研究了包括初始酯化的第二个策略。使用可转化的异氰酸酯检查了构建反式-Pro(3-OH)的方法,该异氰酸酯可以转化为后续酰胺化所需的羧酸。酯键形成是通过使用羟基-Asp 衍生物和相应的醇进行的分子间偶联来实现的,酰胺化得到了线性 depsipeptide。线性肽的大环内酯化得到了环状 depsipeptide,然后进行全局脱保护完成了 1 及其去氧衍生物的全合成。